To obtain documents, log on:
:
Not registered? Register me now
 

Public Higher Education Bulletin

 
University of Illinois at Chicago
Exemption #JMG579
Announcement of an Exempt Purchase
Award Info Published Monday November 12, 2018
Awarded to:
Vendor: Biogen Direct, Cambridge, MA
Amount: An estimated $950,000
Terms:
An estimated start date of 11/6/2018 through 2/1/2019
Renewals:
None
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Monday, November 12, 2018
The University awarded a contract for Tecfidera.
Tecfidera (dimethyl fumarate) is an oral medication used to treat relapse-remitting multiple sclerosis (RRMS).
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Biogen Direct is the exclusive distributor of Tecfidera and without its purchase, patient care and revenue could be compromised.

For additional information, contact:
Janielle Graham
809 S. Marshfield Ave.
3rd Floor
Chicago, IL 60612
Phone: (312) 413-2816
FAX: (312) 996-3135

The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.

Bulletin Navigation

 
To obtain documents, log on:
Exemption Document
  • ExemptionJMG579Biogen.pdf (124 KB)